AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H1696-H1705, 2004. First published January 2, 2004; doi:10.1152/ajpheart.00761.2003
0363-6135/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/5/H1696    most recent
00761.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iemitsu, M.
Right arrow Articles by Yamaguchi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iemitsu, M.
Right arrow Articles by Yamaguchi, I.

Exercise training improves cardiac function-related gene levels through thyroid hormone receptor signaling in aged rats

Motoyuki Iemitsu,1,2,3 Takashi Miyauchi,1,3 Seiji Maeda,2,3 Takumi Tanabe,2 Masakatsu Takanashi,1,3 Mitsuo Matsuda,2 and Iwao Yamaguchi1

1Cardiovascular Division, Department of Internal Medicine, Institute of Clinical Medicine, 2Institute of Health and Sport Sciences, and 3Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba, Ibaraki 305-0006, Japan

Submitted 8 August 2003 ; accepted in final form 22 December 2003


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Exercise training improves the aging-induced downregulation of myosin heavy chain (MHC) and sarcoplasmic reticulum (SR) Ca2+-ATPase, which participate in the regulation of cardiac contraction and relaxation. Thyroid hormone receptor (TR), a transcriptional activator, affected the regulation of gene expression of MHC and SR Ca2+-ATPase. We hypothesized that myocardial TR signaling contributes to a molecular mechanism of exercise training-induced improvement of MHC and SR Ca2+-ATPase genes with cardiac function in old age. We investigated whether TR signaling and gene expression of MHC and SR Ca2+-ATPase in the aged heart are affected by exercise training, using the hearts of sedentary young rats (4 mo old), sedentary aged rats (23 mo old), and trained aged rats (23 mo old, swimming training for 8 wk). Trained aged rats showed improvement in cardiac function. Expression of TR-{alpha}1 and TR-{beta}1 proteins in the heart were significantly lower in sedentary aged rats than in sedentary young rats and were significantly higher in trained aged rats than in sedentary aged rats. The activity of TR DNA binding to the transcriptional regulatory region in the {alpha}-MHC and SR Ca2+-ATPase genes and the mRNA and protein expression of {alpha}-MHC and SR Ca2+-ATPase in the heart and plasma 3,3'-triiodothyronine and thyroxine levels were altered in association with changes in the myocardial TR protein levels. These findings suggest that exercise training improves the aging-induced downregulation of myocardial TR signaling-mediated transcription of MHC and SR Ca2+-ATPase genes, thereby contributing to the improvement of cardiac function in trained aged hearts.

myosin heavy chain; sarcoplasmic reticulum Ca2+-ATPase; swimming training


AGING INDUCES A DECREASE in cardiac function, such as myocardial contraction and relaxation, and the risk of cardiovascular morbidity is increased in the aged heart (3, 20). On the other hand, exercise training improves the aging-induced decrease in myocardial contraction and relaxation (24, 25, 42). The exercise training-induced improvement of cardiac function is a beneficial adaptation for prognosis in the aged heart. However, the molecular mechanisms of the improvement in cardiac function by exercise training are unclear.

Myosin heavy chain (MHC), a contractile protein, has two isoforms, {alpha} and {beta} (30). {alpha}-MHC is associated with high ATPase activity and has a higher contraction velocity in the heart, whereas {beta}-MHC is associated with low ATPase activity and has a slower contraction velocity in the heart (30). Although in the heart of normal adult rats 80–90% of the expressed MHC consists of the {alpha}-form, aging causes a shift of isoform from {alpha}-MHC to {beta}-MHC in the heart (9). In cardiac muscle, the sarcoplasmic reticulum (SR) plays a central role in the contraction and relaxation cycle by regulating the intracellular Ca2+ concentration (44). SR Ca2+-ATPase is a Ca2+ pump that transports Ca2+ into the SR lumen through an ATP-dependent mechanism and is primarily responsible for myocardial relaxation (44). Aging decreases expression of SR Ca2+-ATPase mRNA in the heart (28). On the other hand, exercise training in aged rats improves the aging-induced decrease in expression of SR Ca2+-ATPase mRNA in the heart (47). However, the signaling mechanisms causing to alteration of expression of myocardial {alpha}-MHC and SR Ca2+-ATPase genes with aging and subsequent exercise training are unclear.

Thyroid hormone receptor (TR) binds to thyroid responsive element (TRE) in the promoter regions of several genes, including {alpha}-MHC and SR Ca2+-ATPase in the heart, and regulates the transcription of target genes in the heart (6, 17). TR is the receptor of thyroid hormone and has TR-{alpha}1,-{alpha}2,-{beta}1, and -{beta}2 isoforms (8, 14, 31). The TR-{alpha}2 isoform does not bind thyroid hormone and has a dominant-negative effect on the function of the other receptor isoforms (18, 22). TR-{beta}2 mRNA is not detected in the rat heart (6). TR-{alpha}1 and -{beta}1 are expressed in the heart and are functional receptors, which bind thyroid hormone with similar affinity (18, 22, 39). Furthermore, retinoid X receptor (RXR) plays a role in forming heterodimers with TRs to bind to TRE in the promoter regions of target genes and has RXR-{alpha}, -{beta}, and -{gamma} isoforms (23, 50, 52). It has been reported (27) that aging induced a decrease in mRNA expression of TR-{alpha}1, -{beta}1, and RXR-{gamma} and protein expression of TR-{beta}1 in the heart. However, it is unknown whether exercise training in the aged rat improves aging induced downregulation of the gene and protein levels of myocardial TR. Furthermore, although myocardial TR signaling participates in the transcriptional regulation of {alpha}-MHC and SR Ca2+-ATPase genes, it is unclear whether alterations of TR signaling induce changes in the target genes in the heart.

We hypothesized that exercise training during old age improved aging-induced downregulation of myocardial TR signaling, and the improvement of TR signaling causes changes of {alpha}-MHC and SR Ca2+-ATPase genes in the heart with change of cardiac function. In the present study, we tested our hypothesis by using sedentary young rats (SY group; 4 mo old), sedentary aged rats (SA group; 23 mo old), and swim-trained aged rats (TA group; 23 mo old, swimming training for 8 wk, 5 days/wk, and 90 min/day). We investigated the protein expression of TRs and RXRs and activity of TR DNA binding to TRE in the heart with aging and subsequent exercise training. We also studied the level of mRNA and protein of MHC and SR Ca2+-ATPase in the heart with aging and subsequent exercise training.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals and protocol. The experimental protocols were approved by the Committee on Animal Research at the University of Tsukuba. Male 2- and 21-mo-old Wistar rats were obtained from the Institute for Animal Reproduction (Ibaraki, Japan) and cared for according to the Guiding Principles for the Care and Use of Animals based on the Helsinki Declaration of 1964. These rats were maintained on a 12:12-h light-dark cycle and received food and water ad libitum. Seven 21-mo-old rats were exercised by swimming for 5 days/wk (TA group) in a tank of water at 35–37° C with a surface area of 2,830 cm2 and a depth of 60 cm. The animals were swum as a group of three or four rats because the intensity of swimming exercise was significantly raised by any interaction among the rats. The rats swam for 15 min/day for the first 2 days; the swimming time was then gradually increased in 1-wk periods from 15 to 90 min/day. Thereafter, the TA group continued swimming training for 7 wk. Therefore, the TA group received 8 wk of swimming training. Seven 21-mo-old rats (SA group) and seven 2-mo-old rats (SY group) were confined to their cages for 8 wk but were handled daily. Measurements of body weight and echocardiography after swimming training for 8 wk were performed after rats rested for 24 h. Therefore, it was considered that there was no acute effect from the most recent bout of exercise. After these measurements, the heart and epitrochlearis muscle were removed, rinsed in ice-cold saline, weighed, and frozen in liquid nitrogen. Heart samples were stored at –80° C for determination of the mRNA expression of MHC and SR Ca2+-ATPase by RT-PCR analysis, MHC isoforms by electrophoretic separation analysis, protein levels of SR Ca2+-ATPase, TR-{alpha}1, TR-{beta}1, RXR-{alpha}, RXR-{beta}, and RXR-{gamma} by Western blot analysis, and activity of TR DNA binding to TRE by gel mobility shift assay. The epitrochlearis muscle was chosen for measurement of citrate synthase activity because a previous study (7) reported that swimming training caused the increase in citrate synthase activity in the epitrochlearis muscle. Therefore, the epitrochlearis muscle samples were also stored at –80° C. SY rats and SA rats were euthanized at the same time point as the TA rats (SY rats: 4 mo old, SA rats: 23 mo old, and TA rats: 23 mo old).

Measurements of two-dimensional echocardiography. On the day of the experiment, the rats were anesthetized with pentobarbital sodium (40 mg/kg body wt ip) and transthoracic echocardiography was performed with an echocardiographic system (model SSD-900, Aloka; Tokyo, Japan) equipped with a 7.5-MHz convex scan probe (model VST-987-7.5, Aloka) as described in our previous studies (11). We determined the heart rate (HR), left ventricular (LV) enddiastolic diameter (LVEDD), LV end-systolic diameter (LVESD), LV fractional shortening (LVFS), which was calculated according to the following formula: LVFS (%) = [(LVEDD – LVESD)/LVEDD] x 100, LV ejection fraction (LVEF), which was calculated according to the following formula: LVEF (%) = [(LVEDD)3 – (LVESD)3/(LVEDD)3] x 100, and stroke volume (SV), which was calculated according to the following formula (Pombo method): SV = (LVEDD)3 (LVESD)3.

Muscle oxidative enzyme activity. Citrate synthase activity, a marker of mitochondrial content, was measured in the whole epitrochlearis muscle homogenate using the spectrophotometric method of Srere et al. (41).

RT-PCR to determine levels of mRNA expression in heart. The expression of MHC and SR Ca2+-ATPase mRNA in the left ventricle was analyzed by RT-PCR. The expression of {beta}-actin mRNA was determined as an internal control. Semiquantitative RT-PCR was performed according to the method described in our previous studies (10, 12).

Total tissue RNA was isolated by acid guanidinium thiocyanate-phenol-chloroform extraction with Isogen (Nippon Gene; Toyama, Japan) according to the method described in our previous studies (10, 12).

Total tissue RNA (10 µg) was primed with 0.05 µg of oligo d(pT)12–18 and reverse transcribed by avian myeloblastosis virus reverse transcriptase using a first-strand cDNA synthesis kit (Life Sciences). The reaction was performed at 43° C for 60 min.

The cDNA was diluted in a 1:10 ratio, and 1 µl was used for PCR. Each PCR reaction contained 10 mM Tris·HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, dNTP at 200 µM each, gene-specific primer at 0.5 µM each, and 0.025 U/µl Taq polymerase (Takara). The gene-specific primers were synthesized according to the published cDNA sequences for each of the following: MHC (19), SR Ca2+-ATPase (26), and {beta}-actin (32). The sequences of the oligonucleotides were as follows: MHC (sense), 5'-GCAGACCATCAAGGACCT-3'; MHC (antisense), 5'-GTTGGCCTGTTCCTCCGCC-3'; SRCa2+-ATPase (sense), 5'-CTCAGACAAGACCGGCACACT-3'; SR Ca2+-ATPase (antisense), 5'-ACACCTTCTGGAGCACCCTTC-3'; {beta}-actin (sense), 5'-GAAGATCCTGACCGAGCGTG-3'; and {beta}-actin (antisense), 5'-CGTACTCCTGCTTGCTGATCC-3'

PCR was carried out using a PCR thermal cycler (model TP-3000, Takara). The cycle profile included denaturation for 15 s at 94° C, annealing for each suitable time at each suitable temperature, and extension for each suitable time at 72° C. The annealing time and temperature were set as follows: 15 s at 63° C for MHC, 15 s at 71° C for SR Ca2+-ATPase, and 15 s at 72° C for {beta}-actin. The extension time was set as follows: 45 s for MHC and 60 s for SR Ca2+-ATPase and {beta}-actin. The reaction cycles of PCR were performed in a range that demonstrated a linear correlation between the amount of cDNA and the yield of PCR products. The PCR products were found to be of the expected size, as shown by 1.2% agarose gel electrophoresis for SR Ca2+-ATPase and {beta}-actin. Distinction between {alpha}-MHC and {beta}-MHC was determined by a restriction endonuclease digestion method (10, 15). After PCR in MHC, distinction between {alpha}-MHC and {beta}-MHC was achieved by digestion of 12.5 µl of the PCR reaction mixture with 0.8 units MseI, which recognizes the sequences "TTAA" in a standard reaction buffer at 37° C for 4 h (10). Because the recognition site exists only in the amplicon for {beta}-MHC but not in that of {alpha}-MHC, the reaction yielded fragments of 310 bp for {alpha}-MHC and 275 + 53 bp for {beta}-MHC. The fragments were electrophoresed in 2.0% agarose gel and separated. In addition, the specificity of the amplified sequences was confirmed by restriction enzyme analysis and DNA sequencing. The DNA sequence of each amplicon was perfectly matched to each published sequence.

Semiquantitative analysis of PCR products. We performed semiquantitative PCR analysis to evaluate the expression levels of MHC mRNA, SR Ca2+-ATPase mRNA, and {beta}-actin mRNA. The amplified PCR products were electrophoresed on a 1.2% or 2.0% agarose gels, stained with ethidium bromide, visualized by an ultraviolet transilluminator, and photographed according to the method described in our previous studies (10, 12). The photographs were scanned (CanoScan model 600, Canon; Tokyo, Japan), and quantification was performed with a computer using MacBAS software (Fuji Film; Tokyo, Japan) according to the method described in our previous studies (10, 12). The cDNAs for the verification of the semiquantitative PCR analysis were prepared from each gene PCR product of rat cDNA. Each PCR product was purified, quantified, and used as a positive-control cDNA. Each PCR product concentration was calculated by assuming that the mass of a nucleotide pair in DNA is 660 Da (38). We performed semiquantitative PCR analysis to evaluate the expression level of MHC mRNA, SR Ca2+-ATPase mRNA, and {beta}-actin mRNA. To demonstrate that our semiquantitative PCR strategy was valid, serial dilutions of each positive control cDNA were amplified by PCR and quantified by scanner.

Electrophoretic separation analysis for measurement of MHC isoforms in heart. Electrophoretic separation analysis using SDS-polyacrylamide gel was performed by the method described by Talmadge and Roy (45) and Reiser et al. (34) with minor modification. The stacking and separating gels consisted of 4% and 8% acrylamide, respectively, with acrylamide: N,N'-methylene-bis-acrylamide in the ratio of 50:1 (45). The gels were stained with Coomassie brilliant blue and performed scanning to evaluate the isoform of {alpha}-MHC and {beta}-MHC.

Electrophoresis and immunoblot analysis for measurement of SR Ca2+-ATPase, TR, and RXR proteins in heart. Western blot analysis of SR Ca2+-ATPase protein (37) and TR and RXR proteins (16) was performed according to previous studies with minor modification. Briefly, each sample was separated on SDS-polyacrylamide gel (10%) and then transferred to polyvinylidene difluoride (Millipore; Tokyo, Japan) membranes at 3 mA/cm2 for 60 min. The membrane was treated with blocking buffer and 5% skim milk (SR Ca2+-ATPase) or 3% skim milk (TR and RXR) in PBS with 0.1% Tween 20 (PBS-T) for 12 h at 4° C. The membrane was probed with polyclonal anti-TR-{alpha}1, RXR-{alpha}, RXR-{beta}, and RXR-{gamma} antibody (1:1,000 dilution with blocking buffer, Santa Cruz Biotechnology) and monoclonal anti-SR Ca2+-ATPase (1:500 dilution with blocking buffer, Affinity Bioreagents; Golden, CO) and anti-TR-{beta}1 antibody (1:500 dilution with blocking buffer, Santa Cruz Biotechnology) for 1 h at room temperature, washed with PBS-T three times, and then incubated with a horseradish peroxidase-conjugated secondary antibody, which was an anti-rabbit immunoglobulin (1:5,000 dilution with blocking buffer, Amersham Life Science), and an anti-mouse immunoglobulin (1: 2,000 dilution with blocking buffer, Amersham Life Science) for 1 h at room temperature. After this reaction, the membrane was washed with PBS-T three times. Finally, SR Ca2+-ATPase, TR-{alpha}1, TR-{beta}1, RXR-{alpha}, RXR-{beta}, and RXR-{gamma} were detected by an ECL system (Amersham Life Science) and exposed to Hyperfilm (Amersham Life Science).

Gel mobility shift assays. Gel mobility shift assays using the myocardial nuclear extracts were performed by the method described by Ojamaa et al. (33) and Rohrer et al. (35) with minor modification. Briefly, the samples of LV nuclear extracts (15 µg of protein) were incubated with 50,000 cpm 32P-labeled double-stranded oligonucleotide probes containing the consensus TR binding sequence (5'-GCTGTCCTCCTGTCACCTCCAGA-3') of the promoter region of {alpha}-MHC and the consensus TR binding sequence (5'-GCCGCGACCGCGTAAGGTCGGGCT-3') of the promoter region of SR Ca2+-ATPase at room temperature for 20 min in 10 µl of binding buffer, consisting of 10 mM Tris·HCl (pH 7.5), 50 mM NaCl, 0.5 mM EDTA, 1 mM MgCl2, 0.5 mM DTT, 4% glycerol, and 0.05 mg/ml poly[dI-dC]. The DNA protein complexes were electrophoresed on 4% nondenaturing polyacrylamide gel, and the gel was then dried, subjected to autoradiography, and analyzed with a bioimaging analyzer (BAS-5000, Fuji Film).

Measurements of plasma thyroid hormone level. The plasma 3,3',5-triiodothyronine (T3) and thyroxine (T4) were measured by using radioimmunoassay in duplicate by previously described methods (51).

Statistical analysis. Values are expressed as means ± SE. Statistical analysis was carried out by analysis of variance, followed by Scheffé's F-test for multiple comparisons. P < 0.05 was accepted as significant.


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Body weight was significantly lower in the TA group than in the SA group (Table 1). LV weight (LVW) in the SA group and TA group was significantly higher than that in the SY group (Table 1). LVW mass index for body weight in the TA group was significantly higher than that in the SA group (Table 1). Citrate synthase activity in the epitrochlearis muscle was significantly lower in the SA group than in the SY group and was significantly higher in the TA group than in the SA group (Table 1). These results suggest that the TA rats exhibited physiological effects of exercise training.


View this table:
[in this window]
[in a new window]
 
Table 1. Body weight, left ventricular weight, and muscle oxidative enzyme activity in sedentary young, sedentary aged, and trained aged rats

 

There was no significant difference in LV mass between the SA and TA groups (1.02 ± 0.09 vs. 1.25 ± 0.11 mg). LVEDD was higher in the TA group than in the SA group (Table 2). There was no significant difference in LVESD between the SA and TA groups (Table 2). LVFS and LVEF were significantly lower in the SA group than in the SY group and were significantly higher in the TA group than in the SA group (Table 2). SV was higher in the TA group than in the SA group (Table 2). There was no significant difference in resting HR between the SY and SA groups (Table 2). Resting HR in the TA group was significantly lower than that in the SY and SA groups (Table 2).


View this table:
[in this window]
[in a new window]
 
Table 2. Echocardiographic data in sedentary young, sedentary aged, and trained aged rats

 

To semiquantitatively determine alterations in gene expression of MHC and SR Ca2+-ATPase by aging and subsequent exercise training, the relationship between the amount of cDNA and the yield of PCR products was examined. There was a linear correlation between the initial amount of {beta}-actin cDNA and the yield of PCR products (r = 0.999). In the cases of MHC and SR Ca2+-ATPase, the yield of PCR products was also in proportion to the initial amount of cDNA (r = 0.996 and r = 0.998, respectively). These relationships in control rats were similar to exercise rats. Figure 1A shows typical examples of RT-PCR analysis of {alpha}-MHC and {beta}-MHC in the heart in SY, SA, and TA rats. The mRNA expression of {alpha}-MHC in the heart was markedly lower in the SA group than in the SY group and was significantly higher in the TA group than in the SA group (Fig. 1B). The mRNA expression of {beta}-MHC in the heart was markedly higher in the SA group than in the SY group, and there was no significant difference in mRNA expression of {beta}-MHC between the SA and TA groups (Fig. 1B). Therefore, {beta}-MHC/{alpha}-MHC mRNA expression in the heart, which indicates the shift of isoform from {alpha}-MHC to {beta}-MHC in the heart, was markedly higher in the SA group than in the SY group and was significantly lower in the TA group than in the SA group (Fig. 1B).



View larger version (44K):
[in this window]
[in a new window]
 
Fig. 1. Expression of {alpha}-myosin heavy chain ({alpha}-MHC) mRNA, {beta}-MHC mRNA, and {beta}-MHC/{alpha}-MHC mRNA in the heart (left ventricle) of the sedentary young group (SY; n = 7), sedentary aged group (SA; n = 7), and trained aged group (TA; n = 7, swimming training for 8 wk). A: typical examples of RT-PCR analysis are shown for the levels of {alpha}-MHC and {beta}-MHC mRNA. B: results of statistical analysis of the levels of expression of {alpha}-MHC, {beta}-MHC, and {beta}/{alpha}-MHC mRNA, as determined with the use of a densitometer. The expression of {beta}-actin mRNA was determined as an internal control. Photos of PCR products were scanned by a densitometer, and the ratios of {alpha}-MHC and {beta}-MHC mRNA to {beta}-actin mRNA were calculated. Thus the levels of expression of {alpha}-MHC and {beta}-MHC mRNA were normalized by that of {beta}-actin mRNA. Data are expressed as means ± SE.

 

The mRNA expression of SR Ca2+-ATPase in the heart was markedly lower in the SA group than in the SY group and was markedly higher in the TA group than in the SA group (Fig. 2).



View larger version (29K):
[in this window]
[in a new window]
 
Fig. 2. Expression of sarcoplasmic reticulum (SR) Ca2+-ATPase mRNA in the heart (left ventricle) of the SY group (n = 7), the SA group (n = 7), and the TA group (n = 7, swimming training for 8 wk). Typical examples of RT-PCR analysis are shown for the levels of SR Ca2+-ATPase mRNA (top). Results of statistical analysis of the level of expression of SR Ca2+-ATPase mRNA were determined with a densitometer (bottom). The expression of {beta}-actin mRNA was determined as an internal control. Photos of PCR products were scanned by a densitometer, and the ratio of SR Ca2+-ATPase mRNA to {beta}-actin mRNA was calculated. Thus the level of expression of SR Ca2+-ATPase mRNA was normalized by that of {beta}-actin mRNA. Data are expressed as means ± SE.

 

Figure 3 shows typical examples of electrophoretic separation analysis of MHC isoforms in the heart in SY, SA, and TA rats. The heart of SY rats mainly expressed isoform of {alpha}-MHC, whereas the heart of SA rats equally expressed between {alpha}-MHC and {beta}-MHC isoforms (Fig. 3). The heart of TA rats expressed more {alpha}-MHC isoform than {beta}-MHC isoform (Fig. 3). Therefore, {beta}-MHC/{alpha}-MHC expression in the heart, which indicates the shift of isoform from {alpha}-MHC to {beta}-MHC in the heart, was significantly higher in the SA group than in the SY group and was significantly lower in the TA group than in the SA group (Fig. 3).



View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3. Expression of {alpha}-MHC and {beta}-MHC isoforms in the heart (left ventricle) of SY (n = 7), SA (n = 7), and TA (n = 7) groups. Left, typical examples of electrophoretic separation analysis are shown for the levels of {alpha}-MHC and {beta}-MHC isoforms. Right, results of statistical analysis of the level of expression of {beta}/{alpha}-MHC, as determined by a densitometer. Data are expressed as means and SE.

 

The protein expression of SR Ca2+-ATPase in the heart was significantly lower in the SA group than in the SY group and was significantly higher in the TA group than in the SA group (Fig. 4).



View larger version (30K):
[in this window]
[in a new window]
 
Fig. 4. Expression of SR Ca2+-ATPase protein in the heart (left ventricle) of SY (n = 7), SA (n = 7), and TA (n = 7) groups. Typical examples of Western blot analysis are shown for the levels of SR Ca2+ATPase protein (left). Arrow indicates the immunoblot band for SR Ca2+-ATPase protein. Right, result of statistical analysis of the level of expression of SR Ca2+-ATPase protein determined by a densitometer. Data are expressed as means ± SE.

 

The protein expression of TR-{alpha}1 and TR-{beta}1 in the heart was significantly lower in the SA group than in the SY group and was significantly higher in the TA group than in the SA group (Fig. 5, A and B).



View larger version (33K):
[in this window]
[in a new window]
 
Fig. 5. Expression of thyroid hormone receptor (TR)-{alpha}1 protein (A) and TR-{beta}1 protein (B) in the heart (left ventricle) of SY (n = 7), SA (n = 7), and TA (n = 7) groups. Typical examples of Western blot analysis are shown for the levels of TR-{alpha}1 and TR-{beta}1 proteins (left). Arrows indicate the immunoblot band for TR-{alpha}1 protein and TR-{beta}1 protein. Right, results of statistical analysis of the levels of expression of TR-{alpha}1 and TR-{beta}1 proteins determined by a densitometer. Data are expressed as means ± SE.

 

We performed gel mobility shift assay of myocardial TR DNA binding to examine whether a change in myocardial TR protein affects the activity of TR DNA binding to TREs, which are TR binding domains of the {alpha}-MHC and SR Ca2+-ATPase genes. Figure 4 shows representative films of gel mobility shift assay of myocardial TR DNA binding in the SY, SA, and TA groups. The activity of TR DNA binding was decreased by addition of each unlabeled (competitive) TRE consensus oligonucleotide of {alpha}-MHC and SR Ca2+-ATPase genes in a dose-dependent manner (Fig. 6A). Therefore, these data indicate that this binding occurred specifically with TRE, which is the TR binding domain of the transcriptional regulating regions in the {alpha}-MHC and SR Ca2+-ATPase genes, in the heart. The activity of myocardial TR DNA binding using TRE oligonucleotides of each promoter region in the {alpha}-MHC and SR Ca2+-ATPase genes was lower in the SA group than in the SY group and was higher in the TA group than in the SA group (Fig. 6B).



View larger version (64K):
[in this window]
[in a new window]
 
Fig. 6. Typical examples of gel mobility shift assay for the level of TR DNA binding to thyroid response element (TRE), which is the TR binding domain of the transcriptional regulatory region in the {alpha}-MHC and SR Ca2+-ATPase genes, in the heart (left ventricular nuclear extracts). A: each competitive assay for TR DNA binding of {alpha}-MHC (lanes 14) and SR Ca2+ATPase (lanes 58) genes was carried out in the presence of a 50- and 100-fold molar excess of each unlabeled TR oligonucleotide (competitor). Each arrow indicates TR, TR-TRE complex; NS, nonspecific binding; F, free probe. B: activity of TR DNA binding to TRE in heart (left ventricular nuclear extracts) of the SY, SA, and TA groups using each TRE oligonucleotide probe (TRE) of {alpha}-MHC (left) and SR Ca2+ATPase (right). Lanes 13, TRE probe ({alpha}-MHC): SY, SA, and TA rats, respectively (left); lanes 46, TRE probe (SR Ca2+-ATPase): SY, SA, and TA rats, respectively (right).

 

The protein expression of RXR-{alpha}, RXR-{beta}, and RXR-{gamma} in the heart was significantly lower in the SA group than in the SY group (Fig. 7, AC). There was no significant difference in protein expression of RXR-{alpha} between the SA and TA groups (Fig. 7A). The protein expression of RXR-{beta} was significantly higher in the TA group than in the SA group (Fig. 7B). The protein expression of RXR-{gamma} was significantly lower in the TA group than in the SA group (Fig. 7C).



View larger version (32K):
[in this window]
[in a new window]
 
Fig. 7. Expression of retinoid X receptor (RXR)-{alpha} protein (A), RXR-{beta} protein (B), and RXR-{gamma} protein (C) in the heart (left ventricle) of SY (n = 7), SA (n = 7), and TA (n = 7) groups. Typical examples of Western blot analysis of the levels of RXR-{alpha}, RXR-{beta}, and RXR-{gamma} proteins (left) are shown. Arrows indicate the immunoblot band for RXR-{alpha} protein, RXR-{beta} protein, and RXR-{gamma} protein. Right, results of statistical analysis of the levels of expression of RXR-{alpha}, RXR-{beta}, and RXR-{gamma} proteins determined by a densitometer. Data are expressed as means ± SE.

 

The plasma T3 level was significantly lower in the SA group than in the SY group (Table 3). The plasma T4 level was significantly lower in the SA group than in the SY group and was significantly higher in the TA group than in the SA group (Table 3).


View this table:
[in this window]
[in a new window]
 
Table 3. Plasma thyroid hormone level in sedentary young, sedentary aged, and trained aged rats

 


    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
We demonstrated that exercise training improved the aging-induced decrease in protein expression of TR-{alpha}1 and TR-{beta}1, which are one of the transcriptional regulatory factors of the {alpha}-MHC and SR Ca2+-ATPase genes, in the heart. We also demonstrated that exercise training improved the aging-induced decrease in activity of myocardial TR DNA binding to TREs, which are the TR binding domain of the transcriptional regulatory region in the {alpha}-MHC and SR Ca2+-ATPase genes. Furthermore, exercise training improved the aging-induced decrease in mRNA expression of {alpha}-MHC and SR Ca2+-ATPase in the heart, with improvement of the aging-induced reduction of cardiac function. The present study confirmed that expression of MHC isoforms and SR Ca2+-ATPase protein in the heart was altered in association with changes in mRNA expression of MHC and SR Ca2+-ATPase in the heart. These findings suggest that exercise training improves the aging-induced downregulation of TR signaling in the heart. A previous study (47) has shown that exercise training in aged rat improved aging-induced decrease in expression of SR Ca2+-ATPase mRNA in the heart. It has also been reported that aging-induced decrease in mRNA expression of TR-{alpha}1 and -{beta}1 and protein expression of TR-{beta}1 in the heart (27). Our data are in accordance with these reports (27, 47). Therefore, it is considered that the alteration in gene and protein expression of MHC and SR Ca2+-ATPase in the heart participates in the adaptive mechanism of the change in cardiac function with aging and subsequent exercise training and that myocardial TR signaling-mediated transcriptional regulation participates in the molecular mechanism of the alteration in MHC and SR Ca2+-ATPase genes in the heart with aging and subsequent exercise training. Thus this regulation at the molecular level may contribute to beneficial adaptations through which exercise training improves the aging-induced decrease of cardiac function.

It is well known that the aging-induced decrease in cardiac function is improved by exercise training (24, 25, 42). However, the molecular mechanisms for improving cardiac function are unclear. Myocardial TRs bind to TREs in the promoter regions of several genes, including {alpha}-MHC and SR Ca2+-ATPase in the heart, and regulate transcription of target genes in the heart (6, 17). Kinugawa et al. (16) reported that a rat model of pathological cardiac hypertrophy, which has functional abnormalities in the heart, showed a shift of isozyme from {alpha}-MHC to {beta}-MHC mRNA and a decrease in mRNA expression of SR Ca2+-ATPase in association with a decrease in mRNA expression of TR-{alpha}1 and TR-{beta}1 in the heart. Recently, it has been reported that a lack of TR-{alpha}1 (TR-{alpha}1–/– mice) and TR-{alpha}1/{beta} (TR-{alpha}1–/–/{beta}–/– mice) caused an increase in mRNA expression of {beta}-MHC and a shift of isozyme from {alpha}-MHC to {beta}-MHC protein in the heart, whereas a lack of TR-{beta} (TR-{beta}–/– mice) did not change the protein and mRNA expression of MHC in the heart (29). On the other hand, it has been reported that a rat model of hypothyroidism and a pathological cardiac condition showed an improvement of the decrease in protein or mRNA expression of {alpha}-MHC and SR Ca2+-ATPase in the heart and cardiac function by treatment with T3, which is a ligand for TRs (4, 13). Taken together, these findings suggest that TR signaling regulates target genes encoding {alpha}-MHC and SR Ca2+-ATPase in the heart, and this regulation at the molecular level affects cardiac function. The present study revealed that the myocardial TR-{alpha}1 and TR-{beta}1 proteins and myocardial TR DNA binding are altered in association with changes in the gene expression of {alpha}-MHC and SR Ca2+-ATPase, which are the target genes of TR signaling, in the heart during aging and subsequent exercise training. On the basis of the results from past studies plus the present results, it is considered that exercise training improves the aging-induced downregulation of TR signaling, and this alteration of TR signaling participates in the transcriptional regulation of {alpha}-MHC and SR Ca2+-ATPase genes in the heart, thereby causing adaptation of cardiac function to aging and subsequent exercise training. Therefore, it is possible that the TR signaling-mediated molecular regulation in the heart is a candidate for the molecular mechanism of maintenance and/or upregulation of cardiac function in aging and subsequent exercise training.

In the present study, we measured the protein expression of RXRs in the heart in aging and subsequent exercise training because RXRs play a role in forming heterodimers with TRs to bind to TRE in the promoter regions of target genes (23, 50, 52). The present study revealed that the protein expression of RXR-{alpha}, RXR-{beta}, and RXR-{gamma} in the heart decreased with aging. It has been reported that aging induced decrease in expressions of RXR-{gamma} mRNA and protein in the heart, whereas mRNA expression of RXR-{alpha} and -{beta} did not change (27). The reason for the discrepancy in results between the present study and the previous study is presently unclear. The present study also showed that exercise training induced an increase in RXR-{beta} protein in the aged heart. On the other hand, RXR-{alpha} protein was not changed by exercise training, and RXR-{gamma} protein was decreased by exercise training. These findings suggest that exercise training improves the aging-induced decrease in RXR-{beta} in the heart. Several studies (23, 50) have shown that TRs and RXRs form heterodimers, which bind to TREs of target genes with high affinity and specificity. Therefore, it is possible that the exercise training-induced improvement of RXR-{beta} protein in the aged heart may improve the formation of heterodimers with TRs in the heart, thereby assisting to improve the aging-induced downregulation of myocardial TR signaling, which bind to TRE in the promoter regions of the {alpha}-MHC and SR Ca2+-ATPase genes.

It has been reported that aging caused a decrease in serum or plasma levels of T3 and T4 (2, 46), whereas exercise training caused increase and/or unchanged of serum or plasma levels of T3 and T4 (36, 49). The present study showed that aging decreased in plasma levels of T3 and T4, whereas exercise training improved aging-induced decrease in plasma levels of T4. Therefore, it is considered that TR activation participates in function and signal pathway for aging and exercise training status.

Aging diminished contraction and relaxation response of the heart to {beta}-adrenergic or catecholamine stimulation and increased myocardial working load (21, 42, 43). Several studies (3, 24, 43, 48) also have shown aging-induced reduction of peak early filling rates and diastolic filling volume and aging-induced delay of myocardial contraction and relaxation duration. Furthermore, exercise training improved the aging-induced reduction of cardiac function and performance (24, 42). On the other hand, some studies showed that in a normal aging, resting cardiac function of both animals and humans is unchanged by aging and subsequent exercise training (1, 40). In the present study, SA rats showed a reduction of cardiac function, i.e., a decrease in LVFS and LVEF, whereas TA rats, which received 8-wk swimming training during old age, showed an improvement of cardiac function, i.e., a decrease in resting HR and an increase in LVEDD, LVFS, LVEF, and SV, and developed cardiac hypertrophy. In regard to the difference between our results and several previous results, we calculated LV mass from the echocardiography and investigate to compare this LV mass with measured LVW as an index of reliability of the echocardiographic measurements. Cittadini et al. (5) reported that the echocardiography-calculated LV mass and LVW in the rat was the close correlation (y = 1.03x + 0.05, r = 0.85, P < 0.00001), showing the accuracy of echocardiographic measurements, whereas the echocardiographic measurements in the present study showed a lower but significant correlation between echocardiography-calculated LV mass and LVW (y = 1.06x – 0.46, r = 0.68, P < 0.001) than that in the previous study. Therefore, it is considered that the echocardiographic measurements in the present study may be a relatively lower reliability than in the previous study. The following consideration for analysis by echocardiography is possible. The set of anesthetic doses may affect the hemodynamic status of the animals depending on the amount of fat distribution of the pentobarbital. In the present study, the body weight of rats was markedly increased by aging and was markedly decreased by exercise training. We performed echocardiographic measurements of rats under anesthesia. The anesthetic doses are based on total body weight not lean body weight. Therefore, it is unclear whether the set of anesthetic doses affects hemodynamic status in the aged rats. Furthermore, the present study has the following study limitations. First, the TA rats in the present study experienced dramatic weight loss (27% loss of their body weight in SA rats). Although, in the present study, there may be not only purely a training effect but also is marked other stress related to the swimming, we did not investigate other circulating hormones for this stress. Therefore, it is unclear whether other circulating hormones are changed by this exercise training and these hormones affect the adaptations of cardiac function. Second, the reliance on LVEF as an index of LV contractility may not be ideal because changes in MHC isoforms and probably SR Ca2+-ATPase would be more likely to affect the peak first derivative of LV pressure (dP/dt). Although these hemodynamic measurements should be performed to estimate contraction and relaxation response of the heart with aging and subsequent exercise training, we did not investigate the dP/dt in the heart. Furthermore, these findings of cardiac adaptations in rats with aging and subsequent exercise training may not be analogous to those in humans.

In conclusion, we demonstrated that exercise training during old age improved the aging-induced decrease in protein expression of TR-{alpha}1 and -{beta}1 and activity of myocardial TR DNA binding to TRE. We also demonstrated that exercise training improved the aging-induced decrease in protein expression of RXR-{beta}. These results suggest that exercise training improves the aging-induced downregulation of TR signaling in the heart. This activation of TR signaling pathway in the heart is altered in association with the change in gene and protein expression of MHC and SR Ca2+-ATPase in the heart with aging and subsequent exercise training. Therefore, it is considered that myocardial TR signaling-mediated transcriptional regulation participates in the molecular mechanism of the alteration in MHC and SR Ca2+-ATPase genes in the heart with aging and subsequent exercise training, thereby contributing to the improvement of cardiac function in trained aged hearts. We propose that regulation at the molecular level mediates TR signaling in the heart and partly contributes to the mechanism of the beneficial adaptive responses to exercise training in old age.


    ACKNOWLEDGMENTS
 
We thank Dr. Wendy Gray for editing our manuscript.

GRANTS

This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan (00006132, 00006781, 11557047, and 12470147), a grant from University of Tsukuba Research Projects, and a grant from the project of Tsukuba Advanced Research Alliance in University of Tsukuba.


    FOOTNOTES
 

Address for reprint requests and other correspondence: T. Miyauchi, Cardiovascular Div., Dept. of Internal Medicine, Institute of Clinical Medicine, Univ. of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan (E-mail: t-miyauc{at}md.tsukuba.ac.jp).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Abete P, Calabrese C, Ferrara N, Cioppa A, Pisanelli P, Cacciatore F, Longobardi G, Napoli C, and Rengo F. Exercise training restores ischemic preconditioning in the aging heart. J Am Coll Cardiol 36: 643–650, 2000.[Abstract/Free Full Text]
  2. Buttrick P, Malhotra A, Factor S, Greenen D, Leinwand L, and Scheuer J. Effect of aging and hypertension on myosin biochemistry and gene expression in the rat heart. Circ Res 68: 645–652, 1991.[Abstract/Free Full Text]
  3. Capasso JM, Malhotra A, Remily RM, Scheuer J, and Sonnenblick EH. Effects of age on mechanical and electrical performance of rat myocardium. Am J Physiol Heart Circ Physiol 245: H72–H81, 1983.[Abstract/Free Full Text]
  4. Chang KC, Figueredo VM, Schreur JH, Kariya K, Weiner MW, Simpson PC, and Camacho SA. Thyroid hormone improves function and Ca2+ handling in pressure overload hypertrophy. Association with increased sarcoplasmic reticulum Ca2+-ATPase and {alpha}-myosin heavy chain in rat hearts. J Clin Invest 100: 1742–1749, 1997.[ISI][Medline]
  5. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, and Douglas PS. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 93: 800–809, 1996.[Abstract/Free Full Text]
  6. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med 88: 626–630, 1990.[CrossRef][ISI][Medline]
  7. Hansen PA, McCarthy TJ, Pasia EN, Spina RJ, and Gulve EA. Effects of ovariectomy and exercise training on muscle GLUT-4 content and glucose metabolism in rats. J Appl Physiol 80: 1605–1611, 1996.[Abstract/Free Full Text]
  8. Hodin RA, Lazar MA, Wintman BI, Darling DS, Koenig RJ, Larsen PR, Moore DD, and Chin WW. Identification of a thyroid hormone receptor that is pituitary-specific. Science 244: 76–79, 1989.[Abstract/Free Full Text]
  9. Ieki K, Yazaki Y, Yamaoki K, Tsuchimochi H, Yoshizumi M, Komuro I, Sugiyama T, Seko Y, Takaku F, Kojima M, and Yazaki Y. Effect of long-term treatment with {beta}-blocker on cardiac hypertrophy in SHR. J Mol Cell Cardiol 21, Suppl 5: 113–119, 1989.
  10. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Kobayashi T, Fujii N, Miyazaki H, Matsuda M, and Yamaguchi I. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281: R2029–R2036, 2001.[Abstract/Free Full Text]
  11. Iemitsu M, Miyauchi T, Maeda S, Tanabe T, Takanashi M, Irukayama-Tomobe Y, Sakai S, Ohmori H, Matsuda M, and Yamaguchi I. Aging-induced decrease in the PPAR-{alpha} level in hearts is improved by exercise training. Am J Physiol Heart Circ Physiol 283: H1750–H1760, 2002.[Abstract/Free Full Text]
  12. Iemitsu M, Miyauchi T, Maeda S, Yuki K, Kobayashi T, Kumagai Y, Shimojo N, Yamaguchi I, and Matsuda M. Intense exercise causes decrease in expression of both endothelial NO synthase and tissue NOx level in hearts. Am J Physiol Regul Integr Comp Physiol 279: R951–R959, 2000.[Abstract/Free Full Text]
  13. Izumo S, Lompré AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, and Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 79: 970–977, 1987.[ISI][Medline]
  14. Izumo S and Mahdavi V. Thyroid hormone receptor-{alpha} isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334: 539–542, 1988.[CrossRef][Medline]
  15. Kaddoura S, Firth JD, Boheler KR, Sugden PH, and Poole-Wilson PA. Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist. Circulation 93: 2068–2079, 1996.[Abstract/Free Full Text]
  16. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, and Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circ Res 89: 591–598, 2001.[Abstract/Free Full Text]
  17. Klein I and Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501–509, 2001.[Free Full Text]
  18. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW, and Moore DD. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337: 659–661, 1989.[CrossRef][Medline]
  19. Kraft R, Bravo-Zehnder M, Taylor DA, and Leinwand LA. Complete nucleotide sequence of full length cDNA for rat {beta} cardiac myosin heavy chain. Nucleic Acids Res 17: 7529–7530, 1989.[Free Full Text]
  20. Lakatta EG. Cardiac muscle changes in senescence. Annu Rev Physiol 49: 519–531, 1987.[CrossRef][ISI][Medline]
  21. Lakatta EG, Gerstenblith G, Angell CS, Shock NW, and Weisfeldt ML. Diminished inotropic response of aged myocardium to catecholamines. Circ Res 36: 262–269, 1975.[Abstract/Free Full Text]
  22. Lazar MA, Hodin RA, and Chin WW. Human carboxyl-terminal variant of {alpha}-type c-erbA inhibits trans-activation by thyroid hormone receptors without binding thyroid hormone. Proc Natl Acad Sci USA 86: 7771–7774, 1989.[Abstract/Free Full Text]
  23. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Garnier JM, Mader S, and Charmbon P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377–395, 1992.[CrossRef][ISI][Medline]
  24. Levy WC, Cerqueira MD, Abrass IB, Schwartz RS, and Stratton JR. Endurance exercise training augments diastolic filling at rest and during exercise in healthy young and older men. Circulation 88: 116–126, 1993.[Abstract/Free Full Text]
  25. Li Y, Lincoln T, Mendelowitz D, Grossman W, and Wei JY. Age-related differences in effect of exercise training on cardiac muscle function in rats. Am J Physiol Heart Circ Physiol 251: H12–H18, 1986.[Abstract/Free Full Text]
  26. Lompré AM, de la Bastie D, Boheler KR, and Schwartz K. Characterization and expression of the rat heart sarcoplasmic reticulum Ca2+-ATPase mRNA. FEBS Lett 249: 35–41, 1989.[CrossRef][ISI][Medline]
  27. Long X, Boluyt MO, O'Neill L, Zheng JS, Wu G, Nitta YK, Crow MT, and Lakatta EG. Myocardial retinoid X receptor, thyroid hormone receptor, and myosin heavy chain gene expression in the rat during adult aging. J Gerontol A Biol Sci Med Sci 54: B23–B27, 1999.[Abstract]
  28. Maciel LM, Polikar R, Rohrer D, Popovich BK, and Dillmann WH. Age-induced decreases in the messenger RNA coding for the sarcoplasmic reticulum Ca2+-ATPase of the rat heart. Circ Res 67: 230–234, 1990.[Abstract/Free Full Text]
  29. Mansén A, Yu F, Forrest D, Larsson L, and Vennström B. TRs have common and isoform-specific functions in regulation of the cardiac myosin heavy chain genes. Mol Endocrinol 15: 2106–2114, 2001.[Abstract/Free Full Text]
  30. McNally EM, Kraft R, Bravo-Zehnder M, Taylor DA, and Leinwand LA. Full-length rat alpha and beta cardiac myosin heavy chain sequences. Comparisons suggest a molecular basis for functional differences. J Mol Biol 210: 665–671, 1989.[CrossRef][ISI][Medline]
  31. Mitsuhashi T, Tennyson GE, and Nikodem VM. Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone. Proc Natl Acad Sci USA 85: 5804–5808, 1988.[Abstract/Free Full Text]
  32. Nudel U, Zakut R, Shani M, Neuman S, Levy Z, and Yaffe D. The nucleotide sequence of the rat cytoplasmic {beta}-actin gene. Nucleic Acids Res 11: 1759–1771, 1983.[Abstract/Free Full Text]
  33. Ojamaa K, Samarel AM, and Klein I. Identification of a contractile-responsive element in the cardiac {alpha}-myosin heavy chain gene. J Biol Chem 270: 31276–31281, 1990.
  34. Reiser PJ and Kline WO. Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am J Physiol Heart Circ Physiol 274: H1048–H1053, 1998.[Abstract/Free Full Text]
  35. Rohrer DK, Hartong R, and Dillmann WH. Influence of thyroid hormone and retinoic acid on slow sarcoplasmic reticulum Ca2+ ATPase and myosin heavy chain {alpha} gene expression in cardiac myocytes. Delineation of cis-active DNA elements that confer responsiveness to thyroid hormone but not to retinoic acid. J Biol Chem 266: 8638–8646, 1991.[Abstract/Free Full Text]
  36. Rupp H and Wahl R. Influence of thyroid hormones and catecholamines on myosin of swim-exercised rats. J Appl Physiol 68: 973–978, 1990.[Abstract/Free Full Text]
  37. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, and Masuyama T. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction. Cardiovasc Res 57: 757–765, 2003.[Abstract/Free Full Text]
  38. Sambrook J and Russell DW. Molecular Cloning (3rd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2001, p. A6.5.
  39. Schwartz HL, Strait KA, Ling NC, and Oppenheimer JH. Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J Biol Chem 267: 11794–11799, 1992.[Abstract/Free Full Text]
  40. Seals DR, Hagberg JM, Spina RJ, Rogers MA, Schechtman KB, and Ehsani AA. Enhanced left ventricular performance in endurance trained older men. Circulation 89: 198–205, 1994.[Abstract/Free Full Text]
  41. Srere PA. Citrate synthase. Methods Enzymol 13: 3–6, 1969.
  42. Starnes JW, Beyer RE, and Edington DW. Myocardial adaptations to endurance exercise in aged rats. Am J Physiol Heart Circ Physiol 245: H560–H566, 1983.[Abstract/Free Full Text]
  43. Stratton JR, Levy WC, Schwartz RS, Abrass IB, and Cerqueira MD. {beta}-Adrenergic effects on left ventricular filling: influence of aging and exercise training. J Appl Physiol 77: 2522–2529, 1994.[Abstract/Free Full Text]
  44. Tada M and Katz AM. Phosphorylation of the sarcoplasmic reticulum and sarcolemma. Annu Rev Physiol 44: 401–423, 1982.[CrossRef][ISI][Medline]
  45. Talmadge RJ and Roy RR. Electrophoretic separation of rat skeletal muscle myosin heavy-chain isoforms. J Appl Physiol 75: 2337–2340, 1993.[Abstract/Free Full Text]
  46. Tang F. Effect of sex and age on serum aldosterone and thyroid hormones in the laboratory rat. Horm Metab Res 17: 507–509, 1985.[ISI][Medline]
  47. Tate CA, Helgason T, Hyek MF, McBride RP, Chen M, Richardson MA, and Taffet GE. SERCA2a and mitochondrial cytochrome oxidase expression are increased in hearts of exercise-trained old rats. Am J Physiol Heart Circ Physiol 271: H68–H72, 1996.[Abstract/Free Full Text]
  48. Wei JY, Spurgeon HA, and Lakatta EG. Excitation-contraction in rat myocardium: alterations with adult aging. Am J Physiol Heart Circ Physiol 246: H784–H791, 1984.[Abstract/Free Full Text]
  49. Wirth A, Holm G, Lindstedt G, Lundberg PA, and Bjorntorp P. Thyroid hormones and lipolysis in physically trained rats. Metabolism 30: 237–241, 1981.[CrossRef][ISI][Medline]
  50. Yen PM, Sugawara A, and Chin WW. Triiodothyronine (T3) differentially affects T3-receptor/retinoic acid receptor and T3-receptor/retinoid X receptor heterodimer binding to DNA. J Biol Chem 267: 23248–23252, 1992.[Abstract/Free Full Text]
  51. Young RA, Danforth E Jr, Vagenakis AG, Krupp PP, Frink R, and Sims EA. Seasonal variation and the influence of body temperature on plasma concentrations and binding of thyroxine and triiodothyronine in the woodchuck. Endocrinology 104: 996–999, 1979.[Abstract]
  52. Zhang XK, Hoffmann B, Tran PB, Graupner G, and Pfahl M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355: 441–446, 1992.[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
L. Groban, H. Jobe, M. Lin, T. Houle, D. A. Kitzman, and W. Sonntag
Effects of Short-Term Treadmill Exercise Training or Growth Hormone Supplementation on Diastolic Function and Exercise Tolerance in Old Rats
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2008; 63(9): 911 - 920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Iemitsu, N. Shimojo, S. Maeda, Y. Irukayama-Tomobe, S. Sakai, T. Ohkubo, Y. Tanaka, and T. Miyauchi
The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H136 - H144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. S. Hydock, C.-Y. Lien, C. M. Schneider, and R. Hayward
Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3254 - H3264.
[Abstract] [Full Text] [PDF]